Neurological autoimmunity has a specific ability to effectively target any structure of the peripheral or central nervous system in an extremely specific way and by targeting a very specific cell population, for example the cerebellar purkinje cells.
the Neuro-Autoimmune Disease Diagnostics Markett involve the clinical features, pathophysiology and treatment of various neuro-autoimmune diseases.
When the targeted cell type occurs in different structures of the CNS, the syndrome diversifies concomitantly with myelitis, optic neuritis, and attack of cerebral edema in neuromyelitis optica.
Neuro-autoimmune diseases are essentially caused by damage to the central and peripheral nervous system which helps supply blood vessels, internal organs and the skin.
IQIsolate technology helps to help and identify autoimmune diseases at an early stage.
To treat this type of disorders, some of the diagnostic tests are done including the Antinuclear Antibody (ANA) test, which is done when the autoimmune disorders affect many tissues and organs throughout the body.
This test is used to diagnose systemic lupus erythematosus (SLE).
The autoantibody test is done to test for Sjogren’s syndrome, lupus, autoimmune hepatitis, and rheumatoid arthritis.
The immunoglobulin A (IgA) test is done to test the blood level of immunoglobulin A.
The C-reactive protein (CRP) test is a type of blood test that measures the amount of protein in the blood, known as C-reactive protein.
The complement test is performed to test the activity of the protein group in the serum.
The ESR (erythrocyte sedimentation rate) test is a hematological test that includes the rate at which blood cells sediment.
The protein electrophoresis test measures the specific protein in the blood that helps identify neuro-autoimmune diseases.
Request a sample copy of the report @
Neuro-Autoimmune Disease Diagnostics Market: Drivers and Restraints
The global market for the diagnosis of neuro-autoimmune diseases is driven by the growing awareness of the population about diseases related to the nervous system.
Growing investment from government and hospital institutions for better healthcare is expected to boost the market.
Rising incidence of neurological disease has increased the need for diagnostic procedures, also acts as fuel for the growth of neuro-autoimmune disease diagnostics market and is expected to drive the market over the forecast period.
Lack of knowledge can act as a primary market restraining factor.
Neuroautoimmune Disease Diagnostics Market: Overview
Rising public awareness and rising advanced technologies are expected to drive the market. The neuro-autoimmune disease diagnostics market is categorized by diagnostic test and end-user.
In terms of diagnostic test, the global cardiac rhythm monitoring device market is segmented into antinuclear antibody (ANA) test, autoantibody test, blood test: immunoglobulin A (IgA) test, C-reactive protein (CRP), complement test, ESR (erythrocyte sedimentation rate) test and protein electrophoresis or immunofixation electrophoresis test. By end-user, the global neuro-autoimmune disease diagnostics market is segmented into hospitals, neurodiagnostic test centers and others.
Request a report brochure @
Neuroautoimmune Disease Diagnostics Market: Regional Overview
Based on geography, the global neuro-autoimmune disease diagnostics market is segmented into North America, Latin America, Eastern Europe, Western Europe, Asia-Pacific, Japan, Middle East and Africa.
North America is expected to dominate the market due to better economic conditions, better healthcare facilities, and better government initiatives.
The European market is expected to hold the second largest market share, followed by Latin America due to the growing awareness among the population about neuro-autoimmune diseases.
Do not hesitate to ask questions @
Market: key players
Some of the major players in the neuro-autoimmune disease diagnostics market are Bio-Rad Laboratories, Inc., Crescendo Bioscience, Roche Diagnostics, Quest Diagnostics, Abbott Diagnostics, Beckman Coulter, Inc., SQI Diagnostics, and Euroimmun.
Neuroautoimmune Disease Diagnostics Market: Segmentation
The global neuro-autoimmune disease diagnostics market is categorized on the basis of different diagnostic tests and end users.
The global neuro-autoimmune disease diagnostics market is segmented, by diagnostic test –
- Antinuclear Antibody (ANA) Test
- Autoantibody test
- Blood test: immunoglobulin A (IgA) test
- C-reactive protein (CRP) test
- Complementary test
- ESR test (erythrocyte sedimentation rate)
- Protein electrophoresis test or immunofixation electrophoresis test
The Global Neuro-Autoimmune Disease Diagnostics Market is Segmented, by End-User –
- Neurological diagnostic test centers
About Future Market Insights (IMF)
Future Market Insights (ESOMAR certified market research organization and member of the Greater New York Chamber of Commerce) provides in-depth insights into the driving factors that increase demand in the market.
It reveals opportunities that will drive market growth in various segments on the basis of source, application, sales channel, and end-use over the next 10 years.
Future Market Outlook
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers, Dubai
United Arab Emirates
LinkedIn| Twitter| Blogs